News & Articles

The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality

Infectious disease scientist Dr. Padmapriya Banada explores the potential of cycle threshold values and reveals her melt-based assay alternative

This multi-session event will take you on a weekly path of discovery, featuring the latest in IHC antibodies, histology troubleshooting techniques, case studies in pathology, and more

The test will be widely available to individuals through pharmacies and other locations in accordance with local guidelines and testing strategies

Guest editorial: Learn how clinicians can utilize diagnostic information to make decisions when examining suspected SARS-CoV-2 patients

Explore expert webinars, free downloads, latest methods, and much more to help support biopharmaceutical research

The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples

Both new antibody tests help healthcare teams differentiate the cause of antibodies against SARS-CoV-2

The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods

The test offers 98.0% clinical sensitivity for samples with PCR Ct values up to 31

Reserve your place today for talks on topics ranging from food fraud, spatial infiltration and CRISPR to antibody and AAV gene therapies

The EBV panel can be used to rule out other acute infections, such as missed HIV infections

Next-generation polymer dyes can improve accuracy and brightness with reduced nonspecific staining

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant

Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin

In this on-demand webinar, we look at ways to improve time to result in critical pathways such as sepsis

This partnership aims to offer an accelerated route to market rapid test technologies